PharmExec Picks: Having trouble viewing this e-mail? Click here.

Update My Profile | Advertise With Us | Visit PharmExec.com | PRINT SUBSCRIBE | DIGITAL SUBSCRIBE Pharm Exec Picks is a biweekly eletter that delivers the most popular news and articles from the pharma space and highlights what’s trending on social media. Top 5 Stories : Pharm Exec’s 2015 Emerging Pharma Leaders Slide Show This year's Pharm Exec list of 17 leaders is ripe with the diversified backgrounds and skills required to advance to the “c-suite” in a new era of change for the industry. Read more Pharm Exec's 2015 Pharma 50 Slide Show Our annual Pharma 50 listing is clear proof that once-small and midsize biopharma companies are moving up to join the top ranks of big Pharma. Read more     Medtech M&A's “Huge Impact on Jobs” M&A activity had a huge impact on medtech job numbers in 2014, according to new analysis from EP Vantage. Thanks to its purchase of Covidien, Medtronic (Dublin, Ireland) is now the largest medtech company in terms of headcount, with more than 90,000 on the payroll at the end of its 2014 fiscal year. Read more Biosimilar Litigation: Lessons So Far Congress enacted the Biological Price Competition and Innovation Act (BPCIA) in March 2010, as part of the Affordable Care Act, creating an abbreviated FDA-approval pathway for biological products demonstrated to be “biosimilar” or “interchangeable” with a licensed biologic. Read more Attracting a Millennial Workforce One of the many challenges facing pharmaceutical employers today centers around how to identify and retain the best talent in the marketplace. And competition is fierce. Read more   Sponsored Patient adherence in Germany - benefit vs. cost-containment On Demand Join Joanne Thiele, Market Access Project Manager from Quintiles Germany and Hans Holger Bleβ, Director of Health Services Research department at IGES Institut GmbH as they discuss the importance of patient adherence programs in Germany. Learn more Follow Us   Trending on Social Media : US Biosimilars Industry Calls for Unique HCPCS Codes for Every Product The Biosimilars Forum has written to the Acting Administrator of CMS, Andrew Slavitt, saying that the proposed rule — via the 2016 Medicare Physician Fee Schedule — to use one Healthcare Common Procedure Coding System (HCPCS) J-code for all biosimilars will result in fewer treatment options for patients and providers. Read more Google's Healthcare Ambitions Boosted by Move to Alphabet Google's renaming as Alphabet “spells big things for healthcare”, according to Dan Diamond, writing in Forbes this week. “It positions the tech company to expand into health care, which could be very healthy for its long-term fortunes,” he writes. Read more New Payment Models: It's Time to Move Fundamental changes in the US access and reimbursement landscape are accelerating for the vast majority of public and commercial stakeholders. Often characterized as accountable care organizations (ACOs) or medical homes, these changes are indicative of the larger trend of payers using a variety of payment models to drive an overall behavior change among healthcare professionals and patients. Read more